Noumed Life Sciences Invests in GEA MODUL™ Q Tablet Press Technology
2018-07-19
Noumed Life Sciences, an integrated generics pharmaceutical company that offers a wide range of services and a variety of products, has purchased three MODUL™ Q tablet presses from GEA, along with multiple Exchangeable Compression Module (ECM) turrets to maximize the equipment’s capability and efficiency.